<DOC>
	<DOC>NCT00195273</DOC>
	<brief_summary>The purpose of this study is to compare the kidney function in patients who have received a transplanted kidney and were treated with the combination of sirolimus, daclizumab, mycophenolate and corticosteroids versus transplanted patients treated with cyclosporine, mycophenolate and corticosteroids.</brief_summary>
	<brief_title>Study Evaluating Sirolimus in Kidney Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Graft vs Host Disease</mesh_term>
	<mesh_term>Daclizumab</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Immunoglobulin G</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>Kidney transplantation Donor must be at least 60 years old. Current systemic infection Unstable angina or treatment for serious arrhythmia. Cancer within the previous 5 years.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Kidney</keyword>
	<keyword>Transplant</keyword>
</DOC>